Description: Boston Children's Hospital's science and clinical innovation blog
by Tom Ulrich on October 16, 2014
(stanrandom/Flickr)
This winter, if your doctor suggests that you take Tamiflu, you might want to ask for a conflict of interest statement: a new study suggests that doctors who received payments from the makers of flu-fighting neuraminidase inhibitors—drugs like Tamiflu® and Relenza®—were more likely to view the drugs’ prowess in a favorable light.